aluates Reports

$ 0.0

Automative

Global Orphan Diseases Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-11H6214

Global Orphan Diseases Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Orphan Diseases Market Insights, Forecast to 2029

Code: QYRE-Auto-11H6214

Report

August 2023

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Novartis

Celgene

Roche

Pfizer Inc

Alexion

Sanofi

Vertex Pharmaceuticals

GlaxoSmithKline PLC

Merck

AbbVie

Orphan Diseases Market Size

The global Orphan Diseases market is projected to grow from US$ 306.5 million in 2023 to US$ 676.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 14.1% during the forecast period.

Orphan Diseases Market

An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases have patient populations of fewer than a hundred.

Market Analysis and Insights: Global Orphan Diseases Market

New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.

Report Includes

This report presents an overview of global market for Orphan Diseases market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Orphan Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Orphan Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orphan Diseases revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Orphan Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by therapy area type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Orphan Diseases revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bristol-Myers Squibb, Novartis, Celgene, Roche, Pfizer, Alexion, Sanofi, Vertex Pharmaceuticals and GlaxoSmithKline, etc.

Scope of Orphan Diseases Market Report

Report Metric	Details
Report Name	Orphan Diseases Market
Accounted market size in 2023	US$ 306.5 million
Forecasted market size in 2029	US$ 676.3 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Therapy Area Type	Ocology Hematology Neurology Endocrinology Cardiovascular Respiratory Immunotherapy Others
Segment by Application	Hospital Pharmacy Retail Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Novartis, Celgene, Roche, Pfizer, Alexion, Sanofi, Vertex Pharmaceuticals, GlaxoSmithKline, Merck, Abbvie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Orphan Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Orphan Diseases companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by therapy area type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by therapy area type, by application and by country, revenue for each segment.
Chapter 7: Europe by therapy area type, by application and by country, revenue for each segment.
Chapter 8: China by therapy area type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by therapy area type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by therapy area type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orphan Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Orphan Diseases Market report?

Ans: The main players in the Orphan Diseases Market are Bristol-Myers Squibb, Novartis, Celgene, Roche, Pfizer, Alexion, Sanofi, Vertex Pharmaceuticals, GlaxoSmithKline, Merck, Abbvie

What are the Application segmentation covered in the Orphan Diseases Market report?

Ans: The Applications covered in the Orphan Diseases Market report are Hospital Pharmacy, Retail Pharmacy, Others

What are the Type segmentation covered in the Orphan Diseases Market report?

Ans: The Types covered in the Orphan Diseases Market report are Ocology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Therapy Area Type

1.2.1 Global Orphan Diseases Market Size Growth Rate by Therapy Area Type, 2018 VS 2022 VS 2029

1.2.2 Ocology

1.2.3 Hematology

1.2.4 Neurology

1.2.5 Endocrinology

1.2.6 Cardiovascular

1.2.7 Respiratory

1.2.8 Immunotherapy

1.2.9 Others

1.3 Market by Application

1.3.1 Global Orphan Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Orphan Diseases Market Perspective (2018-2029)

2.2 Global Orphan Diseases Growth Trends by Region

2.2.1 Orphan Diseases Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Orphan Diseases Historic Market Size by Region (2018-2023)

2.2.3 Orphan Diseases Forecasted Market Size by Region (2024-2029)

2.3 Orphan Diseases Market Dynamics

2.3.1 Orphan Diseases Industry Trends

2.3.2 Orphan Diseases Market Drivers

2.3.3 Orphan Diseases Market Challenges

2.3.4 Orphan Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Orphan Diseases by Players

3.1.1 Global Orphan Diseases Revenue by Players (2018-2023)

3.1.2 Global Orphan Diseases Revenue Market Share by Players (2018-2023)

3.2 Global Orphan Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Orphan Diseases, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Orphan Diseases Market Concentration Ratio

3.4.1 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Orphan Diseases Revenue in 2022

3.5 Global Key Players of Orphan Diseases Head office and Area Served

3.6 Global Key Players of Orphan Diseases, Product and Application

3.7 Global Key Players of Orphan Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Orphan Diseases Breakdown Data by Therapy Area Type

4.1 Global Orphan Diseases Historic Market Size by Therapy Area Type (2018-2023)

4.2 Global Orphan Diseases Forecasted Market Size by Therapy Area Type (2024-2029)

5 Orphan Diseases Breakdown Data by Application

5.1 Global Orphan Diseases Historic Market Size by Application (2018-2023)

5.2 Global Orphan Diseases Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Orphan Diseases Market Size (2018-2029)

6.2 North America Orphan Diseases Market Size by Therapy Area Type

6.2.1 North America Orphan Diseases Market Size by Therapy Area Type (2018-2023)

6.2.2 North America Orphan Diseases Market Size by Therapy Area Type (2024-2029)

6.2.3 North America Orphan Diseases Market Share by Therapy Area Type (2018-2029)

6.3 North America Orphan Diseases Market Size by Application

6.3.1 North America Orphan Diseases Market Size by Application (2018-2023)

6.3.2 North America Orphan Diseases Market Size by Application (2024-2029)

6.3.3 North America Orphan Diseases Market Share by Application (2018-2029)

6.4 North America Orphan Diseases Market Size by Country

6.4.1 North America Orphan Diseases Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Orphan Diseases Market Size by Country (2018-2023)

6.4.3 North America Orphan Diseases Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Orphan Diseases Market Size (2018-2029)

7.2 Europe Orphan Diseases Market Size by Therapy Area Type

7.2.1 Europe Orphan Diseases Market Size by Therapy Area Type (2018-2023)

7.2.2 Europe Orphan Diseases Market Size by Therapy Area Type (2024-2029)

7.2.3 Europe Orphan Diseases Market Share by Therapy Area Type (2018-2029)

7.3 Europe Orphan Diseases Market Size by Application

7.3.1 Europe Orphan Diseases Market Size by Application (2018-2023)

7.3.2 Europe Orphan Diseases Market Size by Application (2024-2029)

7.3.3 Europe Orphan Diseases Market Share by Application (2018-2029)

7.4 Europe Orphan Diseases Market Size by Country

7.4.1 Europe Orphan Diseases Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Orphan Diseases Market Size by Country (2018-2023)

7.4.3 Europe Orphan Diseases Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Orphan Diseases Market Size (2018-2029)

8.2 China Orphan Diseases Market Size by Therapy Area Type

8.2.1 China Orphan Diseases Market Size by Therapy Area Type (2018-2023)

8.2.2 China Orphan Diseases Market Size by Therapy Area Type (2024-2029)

8.2.3 China Orphan Diseases Market Share by Therapy Area Type (2018-2029)

8.3 China Orphan Diseases Market Size by Application

8.3.1 China Orphan Diseases Market Size by Application (2018-2023)

8.3.2 China Orphan Diseases Market Size by Application (2024-2029)

8.3.3 China Orphan Diseases Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Orphan Diseases Market Size (2018-2029)

9.2 Asia Orphan Diseases Market Size by Therapy Area Type

9.2.1 Asia Orphan Diseases Market Size by Therapy Area Type (2018-2023)

9.2.2 Asia Orphan Diseases Market Size by Therapy Area Type (2024-2029)

9.2.3 Asia Orphan Diseases Market Share by Therapy Area Type (2018-2029)

9.3 Asia Orphan Diseases Market Size by Application

9.3.1 Asia Orphan Diseases Market Size by Application (2018-2023)

9.3.2 Asia Orphan Diseases Market Size by Application (2024-2029)

9.3.3 Asia Orphan Diseases Market Share by Application (2018-2029)

9.4 Asia Orphan Diseases Market Size by Region

9.4.1 Asia Orphan Diseases Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Orphan Diseases Market Size by Region (2018-2023)

9.4.3 Asia Orphan Diseases Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Orphan Diseases Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Orphan Diseases Market Size by Therapy Area Type

10.2.1 Middle East, Africa, and Latin America Orphan Diseases Market Size by Therapy Area Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Orphan Diseases Market Size by Therapy Area Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Orphan Diseases Market Share by Therapy Area Type (2018-2029)

10.3 Middle East, Africa, and Latin America Orphan Diseases Market Size by Application

10.3.1 Middle East, Africa, and Latin America Orphan Diseases Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Orphan Diseases Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Orphan Diseases Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Orphan Diseases Market Size by Country

10.4.1 Middle East, Africa, and Latin America Orphan Diseases Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Orphan Diseases Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Orphan Diseases Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Orphan Diseases Introduction

11.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2018-2023)

11.1.5 Bristol-Myers Squibb Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Orphan Diseases Introduction

11.2.4 Novartis Revenue in Orphan Diseases Business (2018-2023)

11.2.5 Novartis Recent Developments

11.3 Celgene

11.3.1 Celgene Company Details

11.3.2 Celgene Business Overview

11.3.3 Celgene Orphan Diseases Introduction

11.3.4 Celgene Revenue in Orphan Diseases Business (2018-2023)

11.3.5 Celgene Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Orphan Diseases Introduction

11.4.4 Roche Revenue in Orphan Diseases Business (2018-2023)

11.4.5 Roche Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Orphan Diseases Introduction

11.5.4 Pfizer Revenue in Orphan Diseases Business (2018-2023)

11.5.5 Pfizer Recent Developments

11.6 Alexion

11.6.1 Alexion Company Details

11.6.2 Alexion Business Overview

11.6.3 Alexion Orphan Diseases Introduction

11.6.4 Alexion Revenue in Orphan Diseases Business (2018-2023)

11.6.5 Alexion Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Orphan Diseases Introduction

11.7.4 Sanofi Revenue in Orphan Diseases Business (2018-2023)

11.7.5 Sanofi Recent Developments

11.8 Vertex Pharmaceuticals

11.8.1 Vertex Pharmaceuticals Company Details

11.8.2 Vertex Pharmaceuticals Business Overview

11.8.3 Vertex Pharmaceuticals Orphan Diseases Introduction

11.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2018-2023)

11.8.5 Vertex Pharmaceuticals Recent Developments

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Details

11.9.2 GlaxoSmithKline Business Overview

11.9.3 GlaxoSmithKline Orphan Diseases Introduction

11.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2018-2023)

11.9.5 GlaxoSmithKline Recent Developments

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Orphan Diseases Introduction

11.10.4 Merck Revenue in Orphan Diseases Business (2018-2023)

11.10.5 Merck Recent Developments

11.11 Abbvie

11.11.1 Abbvie Company Details

11.11.2 Abbvie Business Overview

11.11.3 Abbvie Orphan Diseases Introduction

11.11.4 Abbvie Revenue in Orphan Diseases Business (2018-2023)

11.11.5 Abbvie Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol–Myers Squibb

Novartis

Celgene

Roche

Pfizer Inc

Alexion

Sanofi

Vertex Pharmaceuticals

GlaxoSmithKline PLC

Merck

AbbVie

List of Tables

Table 1. Global Orphan Diseases Market Size Growth Rate by Therapy Area Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Ocology

Table 3. Key Players of Hematology

Table 4. Key Players of Neurology

Table 5. Key Players of Endocrinology

Table 6. Key Players of Cardiovascular

Table 7. Key Players of Respiratory

Table 8. Key Players of Immunotherapy

Table 9. Key Players of Others

Table 10. Global Orphan Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 11. Global Orphan Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 12. Global Orphan Diseases Market Size by Region (2018-2023) & (US$ Million)

Table 13. Global Orphan Diseases Market Share by Region (2018-2023)

Table 14. Global Orphan Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 15. Global Orphan Diseases Market Share by Region (2024-2029)

Table 16. Orphan Diseases Market Trends

Table 17. Orphan Diseases Market Drivers

Table 18. Orphan Diseases Market Challenges

Table 19. Orphan Diseases Market Restraints

Table 20. Global Orphan Diseases Revenue by Players (2018-2023) & (US$ Million)

Table 21. Global Orphan Diseases Revenue Share by Players (2018-2023)

Table 22. Global Top Orphan Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Diseases as of 2022)

Table 23. Global Orphan Diseases Industry Ranking 2021 VS 2022 VS 2023

Table 24. Global 5 Largest Players Market Share by Orphan Diseases Revenue (CR5 and HHI) & (2018-2023)

Table 25. Global Key Players of Orphan Diseases, Headquarters and Area Served

Table 26. Global Key Players of Orphan Diseases, Product and Application

Table 27. Global Key Players of Orphan Diseases, Product and Application

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 30. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2018-2023)

Table 31. Global Orphan Diseases Forecasted Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 32. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2024-2029)

Table 33. Global Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 34. Global Orphan Diseases Revenue Share by Application (2018-2023)

Table 35. Global Orphan Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 36. Global Orphan Diseases Revenue Share by Application (2024-2029)

Table 37. North America Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 38. North America Orphan Diseases Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 39. North America Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 40. North America Orphan Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 41. North America Orphan Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 42. North America Orphan Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 43. North America Orphan Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 44. Europe Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 45. Europe Orphan Diseases Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 46. Europe Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 47. Europe Orphan Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 48. Europe Orphan Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. Europe Orphan Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 50. Europe Orphan Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 51. China Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 52. China Orphan Diseases Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 53. China Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 54. China Orphan Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 56. Asia Orphan Diseases Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 57. Asia Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 58. Asia Orphan Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 59. Asia Orphan Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 60. Asia Orphan Diseases Market Size by Region (2018-2023) & (US$ Million)

Table 61. Asia Orphan Diseases Market Size by Region (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Orphan Diseases Market Size by Therapy Area Type (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Orphan Diseases Market Size by Therapy Area Type (2024-2029) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Orphan Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Orphan Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Orphan Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 67. Middle East, Africa, and Latin America Orphan Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 68. Middle East, Africa, and Latin America Orphan Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 69. Bristol-Myers Squibb Company Details

Table 70. Bristol-Myers Squibb Business Overview

Table 71. Bristol-Myers Squibb Orphan Diseases Product

Table 72. Bristol-Myers Squibb Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 73. Bristol-Myers Squibb Recent Developments

Table 74. Novartis Company Details

Table 75. Novartis Business Overview

Table 76. Novartis Orphan Diseases Product

Table 77. Novartis Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 78. Novartis Recent Developments

Table 79. Celgene Company Details

Table 80. Celgene Business Overview

Table 81. Celgene Orphan Diseases Product

Table 82. Celgene Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 83. Celgene Recent Developments

Table 84. Roche Company Details

Table 85. Roche Business Overview

Table 86. Roche Orphan Diseases Product

Table 87. Roche Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 88. Roche Recent Developments

Table 89. Pfizer Company Details

Table 90. Pfizer Business Overview

Table 91. Pfizer Orphan Diseases Product

Table 92. Pfizer Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 93. Pfizer Recent Developments

Table 94. Alexion Company Details

Table 95. Alexion Business Overview

Table 96. Alexion Orphan Diseases Product

Table 97. Alexion Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 98. Alexion Recent Developments

Table 99. Sanofi Company Details

Table 100. Sanofi Business Overview

Table 101. Sanofi Orphan Diseases Product

Table 102. Sanofi Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 103. Sanofi Recent Developments

Table 104. Vertex Pharmaceuticals Company Details

Table 105. Vertex Pharmaceuticals Business Overview

Table 106. Vertex Pharmaceuticals Orphan Diseases Product

Table 107. Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 108. Vertex Pharmaceuticals Recent Developments

Table 109. GlaxoSmithKline Company Details

Table 110. GlaxoSmithKline Business Overview

Table 111. GlaxoSmithKline Orphan Diseases Product

Table 112. GlaxoSmithKline Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 113. GlaxoSmithKline Recent Developments

Table 114. Merck Company Details

Table 115. Merck Business Overview

Table 116. Merck Orphan Diseases Product

Table 117. Merck Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 118. Merck Recent Developments

Table 119. Abbvie Company Details

Table 120. Abbvie Business Overview

Table 121. Abbvie Orphan Diseases Product

Table 122. Abbvie Revenue in Orphan Diseases Business (2018-2023) & (US$ Million)

Table 123. Abbvie Recent Developments

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Orphan Diseases Market Size Growth Rate by Therapy Area Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Orphan Diseases Market Share by Therapy Area Type: 2022 VS 2029

Figure 3. Ocology Features

Figure 4. Hematology Features

Figure 5. Neurology Features

Figure 6. Endocrinology Features

Figure 7. Cardiovascular Features

Figure 8. Respiratory Features

Figure 9. Immunotherapy Features

Figure 10. Others Features

Figure 11. Global Orphan Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 12. Global Orphan Diseases Market Share by Application: 2022 VS 2029

Figure 13. Hospital Pharmacy Case Studies

Figure 14. Retail Pharmacy Case Studies

Figure 15. Others Case Studies

Figure 16. Orphan Diseases Report Years Considered

Figure 17. Global Orphan Diseases Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 18. Global Orphan Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 19. Global Orphan Diseases Market Share by Region: 2022 VS 2029

Figure 20. Global Orphan Diseases Market Share by Players in 2022

Figure 21. Global Top Orphan Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Diseases as of 2022)

Figure 22. The Top 10 and 5 Players Market Share by Orphan Diseases Revenue in 2022

Figure 23. North America Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. North America Orphan Diseases Market Share by Therapy Area Type (2018-2029)

Figure 25. North America Orphan Diseases Market Share by Application (2018-2029)

Figure 26. North America Orphan Diseases Market Share by Country (2018-2029)

Figure 27. United States Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Canada Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Europe Orphan Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 30. Europe Orphan Diseases Market Share by Therapy Area Type (2018-2029)

Figure 31. Europe Orphan Diseases Market Share by Application (2018-2029)

Figure 32. Europe Orphan Diseases Market Share by Country (2018-2029)

Figure 33. Germany Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. France Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. U.K. Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Italy Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Russia Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Nordic Countries Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. China Orphan Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 40. China Orphan Diseases Market Share by Therapy Area Type (2018-2029)

Figure 41. China Orphan Diseases Market Share by Application (2018-2029)

Figure 42. Asia Orphan Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 43. Asia Orphan Diseases Market Share by Therapy Area Type (2018-2029)

Figure 44. Asia Orphan Diseases Market Share by Application (2018-2029)

Figure 45. Asia Orphan Diseases Market Share by Region (2018-2029)

Figure 46. Japan Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. South Korea Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. China Taiwan Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. Southeast Asia Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. India Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Australia Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Orphan Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Orphan Diseases Market Share by Therapy Area Type (2018-2029)

Figure 54. Middle East, Africa, and Latin America Orphan Diseases Market Share by Application (2018-2029)

Figure 55. Middle East, Africa, and Latin America Orphan Diseases Market Share by Country (2018-2029)

Figure 56. Brazil Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Mexico Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Turkey Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. Saudi Arabia Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 60. Israel Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 61. GCC Countries Orphan Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 63. Novartis Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 64. Celgene Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 65. Roche Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 66. Pfizer Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 67. Alexion Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 68. Sanofi Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 69. Vertex Pharmaceuticals Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 70. GlaxoSmithKline Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 71. Merck Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 72. Abbvie Revenue Growth Rate in Orphan Diseases Business (2018-2023)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions